SARS-CoV-2 antibodies decline within 2 months
Antibodies to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) decline during the weeks after infection, in some cases falling below the threshold for seropositivity
US monitoring SARS-CoV-2 Viral Mutation – UK variant
US is alerting clinical laboratory staff and health care providers that the FDA is monitoring the potential impact of viral mutations, including an emerging variant
Covaxin covid-19 vaccine shows robust immune response
India’s indigenous coronavirus vaccine, Covaxin, has shown to generate robust immune response in its first phase clinical trials. A detailed immunogenicity response of the first
Covid-19: Third spike in coronavirus cases in Capital of India
New Delhi state of India is seeing an increase in new cases of covid-19 coronavirus disease. Navratri, Dusshera and Durga Pooja celebrations have a definite
Social distancing will reduce antibiotic resistance
Social distancing may influence the microbiome is by limiting the transmission of antibiotic resistant microbes between people and the exchange of resistance genes between microbes.
COVID-19 infection may have lasting or delayed effects on heart
The number of people coronavirus disease 2019 (COVID-19) is rising with more cases in the U.S. (5M according to the Centers for Disease Control and
Coronavirus vaccine launched by Russia to become first in Coronavirus vaccine race
Russia has developed the first vaccine against the coronavirus. The announcement was made by President Vladimir Putin during a televised video conference call with government
Hydroxychloroquine & lopinavir/ritonavir treatment discontinued for COVID-19
Hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients. WHO accepted the recommendation from the Solidarity Trial’s International Steering
ChAdOx1 nCoV-19 vaccine protects monkeys against COVID-19 pneumonia
A single dose of ChAdOx1 nCoV-19, an investigational vaccine against SARS-CoV-2, has protected six rhesus macaques from pneumonia caused by the virus, according to National
Tabrecta – capmatinib – approved for non-small cell lung cancer in adults
U.S. Food and Drug Administration approved Tabrecta (capmatinib) for the treatment of adult patients with non-small cell lung cancer (NSCLC) that has spread to other